Lamivudine

In the US, Lamivudine (lamivudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B, HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF05

CAS registry number (Chemical Abstracts Service)

0134678-17-4

Chemical Formula

C8-H11-N3-O3-S

Molecular Weight

229

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of hepatitis B

Chemical Names

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (WHO)

(-)-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxythiolan-5-yl]pyrimidin-2(1H)-one (Ph. Int.)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-

Foreign Names

  • Lamivudinum (Latin)
  • Lamivudin (German)
  • Lamivudine (French)
  • Lamivudina (Spanish)

Generic Names

  • Lamivudine (OS: USAN, DCF, BAN)
  • 3-TC (IS)
  • GR 109714 X (IS: Glaxo)
  • Lamivudine (PH: BP 2011, Ph. Eur. 7, Ph. Int. 4, USP 34)
  • Lamivudinum (PH: Ph. Eur. 7, Ph. Int. 4)

Brand Names

  • 3TC COMPLEX (Lamivudine and Zidovudine)
    GlaxoSmithKline, Argentina
  • 3-TC/AZT ELEA (Lamivudine and Zidovudine)
    Elea, Argentina
  • 3TC
    GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, South Korea; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Switzerland
  • 3TC-HBV
    GlaxoSmithKline, Indonesia
  • Adco-Lamivudine
    Adcock Ingram Pharmaceuticals, South Africa
  • Amilitrap
    Dosa, Argentina
  • Antiheb
    Mebiphar, Vietnam
  • Aspen Lamivudine
    Aspen Pharmacare, South Africa
  • Aspen Lamzid (Lamivudine and Zidovudine)
    Aspen Pharmacare, South Africa
  • Avilam
    Beximco, Bangladesh
  • Avocomb (Lamivudine and Zidovudine)
    Ranbaxy Laboratories, Ethiopia
  • Avolam
    Ranbaxy Laboratories, Ethiopia
  • Avudin (Lamivudine and Zidovudine)
    Square, Bangladesh
  • Biovir (Lamivudine and Zidovudine)
    GlaxoSmithKline, Brazil
  • Cipla-Duovir (Lamivudine and Zidovudine)
    Cipla Medpro, South Africa
  • Cipla-Lamivudine
    Cipla Medpro, South Africa
  • Combid (Lamivudine and Zidovudine)
    GlaxoSmithKline, Thailand
  • Combivir (Lamivudine and Zidovudine)
    Glaxo, Latvia; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, United States; ViiV Healthcare ULC, Canada; Viivhiv, Portugal; Wellcome, Bosnia & Herzegowina
  • Coviro (Lamivudine and Stavudine)
    Ranbaxy, Myanmar
  • Cytocom (Lamivudine and Zidovudine)
    Alkem, India
  • Cytocom-N (Lamivudine and Zidovudine, + Nevirapine)
    Alkem, India
  • Diavix (Lamivudine and Zidovudine)
    Beximco, Bangladesh
  • Duovir (Lamivudine and Zidovudine)
    Cipla, Ethiopia; Cipla, India
  • Duovir-N (Lamivudine and Zidovudine, + Nevirapine)
    Cipla, India
  • Duovox (Lamivudine and Zidovudin)
    Biotoscana, Peru
  • Emduo (Lamivudine and Stavudine)
    Emcure, India; Emcure, Myanmar
  • Emduo-JR (Lamivudine and Stavudine (pediatric))
    Emcure, India
  • Emduo-N (Lamivudine and Stavudine, + Nevirapine)
    Emcure, India
  • Emtri (Lamivudine and Stavudine, + Nevirapine)
    Emcure, India; Emcure, Myanmar
  • Emtri JR (Lamivudine and Stavudine, + Nevirapine (pediatric))
    Emcure, India
  • Epivir 3TC
    GlaxoSmithKline, Chile; GlaxoSmithKline, Russian Federation
  • Epivir
    Glaxo, Latvia; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Belgium; GlaxoSmithKline, Brazil; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Peru; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela; ViiV, Austria; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, United States
  • Epivir-HBV
    GlaxoSmithKline, United States
  • Epzicom (Lamivudine and Abacavir)
    GlaxoSmithKline, Japan; ViiV Healthcare, United States
  • Flamivud
    Flamingo Pharmacueticals, Ethiopia
  • Ganvirel
    Ivax, Argentina
  • Ganvirel Duo (Lamivudine and Zidovudine)
    Ivax, Argentina
  • Gpo-Vir (Lamivudine and Nevirapine, + Stavudine)
    GPO, Thailand
  • Hepavir
    Square, Bangladesh
  • Hepitec
    GlaxoSmithKline, India
  • Heptavir
    Hetero, Georgia
  • Heptodin
    GlaxoSmithKline, China
  • Heptodine
    GlaxoSmithKline, Argentina
  • Heptovir
    GlaxoSmithKline, Canada
  • Imunoxa
    Gador, Argentina
  • Inhavir
    Biogen, Colombia
  • Kess
    Filaxis, Argentina
  • Kivexa (Lamivudine and Abacavir)
    Glaxo Group, Poland; Glaxo Group, Slovenia; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Chile; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
  • Ladiwin
    Cadila Health Care, Ethiopia
  • Lamda
    Cadila, India
  • Lamda-Z (Lamivudine and Zidovudine)
    Cadila, India
  • Lamibergen
    Paylos, Argentina
  • Lamidac
    Cadila Health Care, Ethiopia; Zydus, India; Zydus Cadila, Myanmar
  • Lamidin
    Eskayef, Bangladesh; Medibios Laboratories, Ethiopia
  • Lamidine
    Synmosa, Taiwan
  • Lamilea
    Elea, Argentina
  • Lamimac
    Macleods Pharmaceuticals, Ethiopia
  • Lamitec
    Zifam India, Myanmar
  • Lamitec-S (Lamivudine and Stavudine)
    Zifam India, Myanmar
  • Lamivir
    Cipla, Georgia; Cipla, India; Flamingo Pharmacueticals, Ethiopia; GPO, Thailand; Incepta, Bangladesh; Pharmaceutical, Venezuela
  • Lamivir-S (Lamivudine and Stavudine)
    Cipla, India
  • Lamivox
    Aurobindo, Ethiopia; Biotoscana, Peru
  • Lamivudin Hasan
    Hasan, Vietnam
  • Lamivudin Stada
    Stada-VN JV, Vietnam
  • Lamivudina Delta
    Delta Farma, Argentina
  • Lamivudina Microsules
    Microsules, Argentina
  • Lamivudina
    Biocrom, Peru; Induquimica, Peru
  • Lamivudine and Zidovudine Aurobindo (Lamivudine and Zidovudine)
    Aurobindo, United States
  • Lamivudine and Zidovudine Lupin (Lamivudine and Zidovudine)
    Lupin, United States
  • Lamivudine and Zidovudine Teva (Lamivudine and Zidovudine)
    Teva, United States
  • Lamivudine Apotex
    Apotex, United States
  • Lamivudine Aurobindo
    Aurobindo, United States
  • Lamivudine Teva Pharma B.V.
    Teva, Latvia
  • Lamivudine Teva
    Teva, Lithuania; Teva, Latvia
  • Lamivudin-Teva
    Teva Pharma, Switzerland
  • Lamivur
    Cipla, Ethiopia
  • Lamiwudyna/Zydowudyna Mylan (Lamivudine and Zidovudine)
    Mylan, Poland
  • Lamostad (Lamivudine and Stavudine)
    Alkem, India
  • Lamostad-N (Lamivudine and Nevirapine, + Stavudine)
    Alkem, India
  • Lamuzid (Lamivudine and Zidovudine)
    Cadila Health Care, Ethiopia; Zydus, India; Zydus Cadila, Myanmar
  • Lamzidivir (Lamivudine and Zidovudine)
    Stada-VN JV, Vietnam
  • Lamzitrio (Lamivudine and Zidovudine, + Nevirapine)
    Stada-VN JV, Vietnam
  • Lasovir (Lamivudine and Zidovudine)
    Zifam India, Myanmar
  • Lavir
    Emcure, India; Emcure, Myanmar
  • Laviz
    DHG Pharma, Vietnam
  • Lazid (Lamivudine and Stavudine)
    Emcure, Myanmar
  • Lazid (Lamivudine and Zidovudine)
    Emcure, India
  • Lazid-N (Lamivudine and Zidovudine, + Nevirapine)
    Emcure, India
  • Lazivir (Lamivudine and Zidovudine)
    Celon, Poland
  • Maxivir (Lamivudine and Stavudine, + Nevirapine)
    Okasa, Myanmar
  • Medilam (Lamivudine and Stavudine)
    Meditab, Myanmar
  • Medivir (Lamivudine and Zidovudine)
    Meditab, Myanmar
  • Medovir
    Sanovel, Turkey
  • Mivux
    Nobel, Turkey
  • Nevitrio (Lamivudine and Nevirapine, + Stavudine)
    Stada-VN JV, Vietnam
  • Oralmuv
    LKM, Argentina
  • Pilafix
    PMP, Vietnam
  • Retrolam
    Alkem, India
  • Shanvudin
    Shantha, India
  • Sonke-LamiNevStav (Lamivudine and Nevirapine, + Stavudine)
    Ranbaxy, South Africa
  • Sonke-Lamivudine + Zidovudine (Lamivudine and Zidovudine)
    Ranbaxy, South Africa
  • Sonke-Lamivudine
    Ranbaxy, South Africa
  • Sonke-Lastad (Lamivudine and Stavudine)
    Ranbaxy, South Africa
  • Stavex (Lamivudine and Stavudine, + Nevirapine)
    Aurobindo, India
  • Tivizid (Lamivudine and Zidovudine + Abacavir)
    Square, Bangladesh
  • Triomune (Lamivudine and Stavudine, + Nevirapine)
    Cipla Medpro, South Africa
  • Triovix (Lamivudine and Zidovudine + Nevirapine)
    Beximco, Bangladesh
  • Trizivir (Lamivudine and Abacavir, + Zidovudine)
    Glaxo Group, Austria; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; Novo Nordisk, Denmark; Shire, Canada; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, United States; Viivhiv, Portugal
  • Trovir (Lamivudine and Zidovudine, + Nevirapine)
    Zifam India, Myanmar
  • Victron
    ICA Pharmaceuticals, Vietnam
  • Vifix
    PMP, Vietnam
  • Viradin
    Healthcare, Bangladesh
  • Viramid
    Lupin, India
  • Virdual (Lamivudine and Zidovudine)
    Biogen, Colombia
  • Virocomb (Lamivudine and Zidovudine)
    Ranbaxy, India; Ranbaxy, Myanmar
  • Virocomb-N (Lamivudine and Nevirapine, + Zidovudine)
    Ranbaxy, India; Ranbaxy, Myanmar
  • Virolam
    Ranbaxy, India
  • Virolans (Lamivudine and Nevirapine, + Stavudine)
    Ranbaxy, India; Ranbaxy, Myanmar
  • Virolis (Lamivudine and Stavudine)
    Ranbaxy, India
  • Virozen (Lamivudine and Stavudine, + Nevirapine)
    Zifam India, Myanmar
  • Vuclodir
    Richmond, Argentina
  • Vudirax
    Blausiegel, Brazil
  • Zeffix
    Glaxo, Latvia; Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Group Limited-GB, Italy; Glaxo Wellcome, Serbia; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, South Korea; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan
  • Zefix
    GlaxoSmithKline, Japan
  • Zefomen
    Mustafa Nevzat, Turkey

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Int.Pharmacopoea Internationalis
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web4)